Acquired resistance of Mycobacterium tuberculosis to bedaquiline
about
Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsTB drug development: immunology at the tableRelease of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discoveryBedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquilineNew Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaInterplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosisSynthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactamsVerapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model.Drug-resistance mechanisms and tuberculosis drugsMode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosisIdentification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosisSusceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical modelsResistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.QSAR based therapeutic management of M. tuberculosis.Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of TuberculosisNew Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisBedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase.A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.Bedaquiline for the treatment of drug-resistant tuberculosis.Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.Synthetic investigational new drugs for the treatment of tuberculosis.Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.The diverse family of MmpL transporters in mycobacteria: from regulation to antimicrobial developments.Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery.Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.Bedaquiline susceptibility testing of Mycobacterium tuberculosis in an automated liquid culture system.Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish.Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung DiseaseReply: Call for Regular Susceptibility Testing of Bedaquiline and Delamanid.First use of bedaquiline in a patient with XDR-TB in Singapore.
P2860
Q26771997-689A76AA-7426-4BB4-9350-15B0BA28FAFDQ26824413-C9C0D439-198D-49A0-8BD6-AA9D09164A84Q27728459-65641C84-1999-443E-9FC3-10664ED53F00Q28072205-BC3A3E12-C384-460C-9D68-5F9B6E458377Q28083600-5F28CB92-E821-45DD-A730-9DC77E252742Q28551386-EFB304EE-5803-4920-B432-C8E0484B00C0Q30249515-B84EDEC1-654D-48C8-BDE5-FCC14EF5CCC2Q33589758-A4583599-C66C-4DBE-B20F-E0D92BFBA192Q33600161-3D3C1500-492E-4D45-9E31-6CF62859BC26Q33607162-808CE73B-7435-40FE-B564-3C1A1E4CF309Q34229876-E82BD953-3401-4237-A87D-A70836B19947Q34923159-E42E00A8-AB06-4DEB-BC56-D63DD2CCA952Q35218108-075AA6D2-C148-476A-860B-53298B05B8D6Q35859964-FF1522BC-DDD3-4C41-B776-C5FB3F7C0FD2Q35962789-44DE2E68-70DB-43E1-9D4B-27A36323E91CQ36158384-A0B89D6D-14A3-4A7B-A140-49C59D9A1982Q36251994-BD00D272-5F70-4420-80F6-1930CACF7D07Q36359056-71990BE8-0439-40B7-ACD6-054D9B5716F9Q36439105-A4B30654-511A-4F83-BB27-6FB6EE7D28A7Q36644842-D5E80277-0257-42E3-AE31-1ADB899C3FB6Q37120065-D7B66D94-F8EA-41AA-9540-12B63D57D594Q37266676-362F3DC8-9F62-411E-97F1-3AE99C5603D4Q37339294-2EBA4A6D-5197-4CBC-BF6D-05F426834226Q37358778-EE999752-A859-4084-A448-2B64852A2BCFQ37434296-CD92704C-1FCF-4F8E-986D-D310A7984FDBQ38261230-E8ACF835-DDAF-44AC-B746-4F317A7993E4Q38386950-20D30158-97EA-40FE-B1A4-B460A39810DCQ38608754-DBEE3FF3-F803-4D39-AB2B-291A6AD091F0Q38635790-DCF64153-684E-4E43-9A67-9DEC0D224C2DQ38674445-81752A7B-5236-4F9C-8D69-ABE993483159Q38995175-1C7C9C64-711A-4609-A28B-F1BB878EF7D9Q39199131-DB9E6AD3-2536-4304-B681-6443B14689C9Q39235946-BB7B2952-003C-4AA9-ABB8-E9F21DDA0A14Q39284340-5F69D49F-A8C4-4348-8933-B1F8D9EA38A0Q39529865-54F9DA91-C02F-46D2-B835-0EBD30F0DA8DQ40076101-CDA1378E-2335-43A5-B136-2A5DB50BB920Q40093529-D3C26BFF-1889-4712-8431-481409911F7AQ40419592-50488B3D-6DD8-4665-AD8A-6CDE7AEA24DBQ40474623-4C7F4032-2BD5-456D-8720-9D9E575EFE41Q41362907-20687C4E-6C87-4A06-B384-9F8E34910FB7
P2860
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@ast
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@en
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@nl
type
label
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@ast
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@en
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@nl
prefLabel
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@ast
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@en
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@nl
P2093
P2860
P3181
P1433
P1476
Acquired resistance of Mycobacterium tuberculosis to bedaquiline
@en
P2093
Cristina Villellas
Koen Andries
Luc Vranckx
Nacer Lounis
Nele Coeck
Tom Gevers
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0102135
P407
P577
2014-01-01T00:00:00Z